Reveal LINQ™ Heart Failure
NCT02758301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112
Last updated 2019-11-12
Summary
The purpose of the LINQ™ HF study is to characterize Reveal LINQ™ derived data from patients with heart failure by assessing the relationship between changes in LINQ™ derived data and other physiologic parameters with subsequent acute decompensated heart failure (ADHF) events.
Conditions
Interventions
- DEVICE
-
Reveal LINQ™ Insertable Cardiac Monitor (ICM)
Insertable Cardiac Monitor with LINQ™ HF Investigational RAMware download
Sponsors & Collaborators
-
Medtronic Cardiac Rhythm and Heart Failure
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-08
- Primary Completion
- 2018-12-04
- Completion
- 2018-12-04
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
NCT02594488 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure
NCT01486316 ·Status: COMPLETED ·Phase: NA
-
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
NCT03579641 ·Status: COMPLETED
-
Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia
NCT03001765 ·Status: COMPLETED ·Phase: NA
-
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
NCT00279955 ·Status: COMPLETED
-
The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial
NCT02493205 ·Status: COMPLETED
-
Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF
NCT00158951 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
NCT00643279 ·Status: COMPLETED ·Phase: NA
-
Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States
NCT02395536 ·Status: COMPLETED ·Phase: NA
-
Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)
NCT00354159 ·Status: COMPLETED ·Phase: NA
-
MOnitoring REsynchronization deviCes and cARdiac patiEnts
NCT00885677 ·Status: TERMINATED ·Phase: NA
-
OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network
NCT00769457 ·Status: COMPLETED ·Phase: PHASE4
-
Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters
NCT01357408 ·Status: TERMINATED
-
Digital Remote Home Monitoring for Heart Failure
NCT05988749 ·Status: TERMINATED ·Phase: NA
-
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
NCT00991120 ·Status: COMPLETED
-
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
NCT05652218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanically Optimizing Cardiac Preload in Heart Failure Patients
NCT04338503 ·Status: UNKNOWN
-
REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
NCT00271154 ·Status: COMPLETED ·Phase: NA
-
PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing
NCT00409916 ·Status: UNKNOWN ·Phase: PHASE4
-
Validation of CardioMEMS HF System Cardiac Output Algorithm IDE
NCT05428384 ·Status: COMPLETED
-
Comparison of External Event Recorders for Atrial Fibrillation Monitoring
NCT00863382 ·Status: WITHDRAWN ·Phase: NA
-
Hemodynamic-GUIDEd Management of Heart Failure
NCT03387813 ·Status: COMPLETED ·Phase: NA
-
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531 ·Status: COMPLETED ·Phase: PHASE4
-
DECIDE-HF: Heart Rate Variability in Heart Failure Patients
NCT00949676 ·Status: UNKNOWN
-
Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment
NCT01426321 ·Status: COMPLETED ·Phase: NA